Durham drugmaker recaptures pre-Covid momentum for glaucoma treatment
May 06, 2021 at 13:19 PM EDT
The company's year-over-year revenue was up 13 percent for the first quarter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|